Immunotherapies - 1 News by Pathios Therapeutics

Immunotherapies - 1 News by Pathios Therapeutics

image description

Start-up aims to open the door to an entirely new approach to immunotherapy

Pathios Therapeutics raises $25M in first close of Series B financing to advance first-in-class immunotherapy approach into clinic

23-Apr-2024 - Pathios Therapeutics Limited, a biotech company focused on the development of first-in-class therapies for cancer, announced that the company has raised USD $25 million in the first close of a Series B financing. The financing consists of a new strategic investment from Bristol Myers Squibb, as ...

immunotherapies cancer immunotherapies cancer

These products might interest you

ZE5 Cell Analyzer

ZE5 Cell Analyzer by Bio-Rad Laboratories

Fast and precise flow cytometry for high-throughput analyses

Reduce labour and increase productivity in drug discovery

flow cytometers
View product
Show all immunotherapies
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,241 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now